RIGL - Rigel Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts5565
Avg. Estimate-0.17-0.17-0.67-0.47
Low Estimate-0.18-0.19-0.74-0.59
High Estimate-0.16-0.15-0.6-0.4
Year Ago EPS-0.13-0.16-0.62-0.67
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts5565
Avg. Estimate60k220k7.97M40.9M
Low EstimateN/AN/A2.71M26.21M
High Estimate200k820k18M48.12M
Year Ago Sales3.58MN/A4.48M7.97M
Sales Growth (year/est)-98.30%N/A77.70%413.20%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-0.12-0.15-0.15-0.13
EPS Actual-0.13-0.16-0.14-0.18
Difference-0.01-0.010.01-0.05
Surprise %-8.30%-6.70%6.70%-38.50%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.17-0.17-0.67-0.47
7 Days Ago-0.18-0.18-0.68-0.47
30 Days Ago-0.16-0.16-0.63-0.2
60 Days Ago-0.14-0.15-0.53-0.24
90 Days Ago-0.14-0.15-0.53-0.24
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 Days111N/A
Up Last 30 Days111N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRIGLIndustrySectorS&P 500
Current Qtr.-30.80%N/AN/A0.42
Next Qtr.-6.30%N/AN/A0.38
Current Year-8.10%N/AN/A0.20
Next Year29.90%N/AN/A0.10
Next 5 Years (per annum)61.00%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A